Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
Austin, Texas--(Newsfile Corp. - March 5, 2025) - Maxwell Biosciences, a preclinical drug platform company that develops Claromers TM, synthetic small molecules that mimic and improve upon the natural immune system, today announced a new collaboration. Maxwell has entered into a Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research (USAISR). Using their research experience and resources, the U.S. Army will conduct studies to support development of Maxwell's therapeutics that will treat viral, bacterial and fungal threats. This agreement marks the sixth research agreement between Maxwell and U.S. military branches.
To view an enhanced version of this graphic, please visit:
USAISR's laboratory will initially conduct in vitro studies with potential subsequent in vivo safety studies to explore core scientific aspects of Claromers TM. These studies will provide both the U.S. Army and Maxwell with crucial data needed for safe drug development.
This research collaboration between the U.S. Army and Maxwell offers a unique opportunity to enhance treatment options for priority pathogens, especially for those lacking vaccines or therapies. If successful, Maxwell's drug pipeline could improve outcomes for warfighters and civilians.
'The Claromer TM family of compounds represents a novel breakthrough,' said Scotch McClure, CEO of Maxwell Biosciences. 'We're delighted that the U.S. Army is as equally motivated as we are to research fundamental scientific aspects of these compounds. There's so much we can learn by working hand-in-hand with military scientists.'
About USAISR
USAISR is focused on optimizing care for combat-injured patients. The USAISR Burn Center provides specialty care for burn and burn-like injuries. As the Department of Defense's primary laboratory, USAISR partners with hundreds of academic, industry and allied nation military laboratories.
About Maxwell Biosciences
Founded in 2016, Maxwell Biosciences is a preclinical drug platform company that develops Claromers TM, synthetic small molecules that mimic and improve upon the natural immune system. Inspired by nature, these deep tech breakthrough molecules have been shown to be effective against Ebola, pan-coronavirus and pan-Influenza A (avian, swine and human) in destroying viruses, but also all tested bacteria, fungi and biofilms with a single compound, while safely preserving healthy cells. This new 'One Drug for Many Bugs' technology has been shown to be well-tolerated in lab-grown human tissues and in multiple animal studies and is shelf-stable. The compounds imitate key components of the innate immune system: humanity's greatest asset in fighting disease. Maxwell's technology is protected by numerous granted and pending patents and is led by a world-class team of scientists, military veterans and experienced life science executives.
Contacts
Media
Disclaimer
The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the U.S. Government.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
a day ago
David Nabarro, British physician who led UN response to Ebola and COVID-19, dies
GENEVA -- Dr. David Nabarro, a British physician who led the U.N. response to some of the biggest health crises in recent years, including bird flu, Ebola and the coronavirus pandemic, has died. He was 75. Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, confirmed Nabarro's death on social media platform X. 'David was a great champion of global health and health equity, and a wise, generous mentor to countless individuals,' Tedros wrote Saturday. 'His work touched and impacted so many lives across the world.' King Charles III knighted Nabarro in 2023 for his contributions to global health after he served as one of six special envoys to the WHO on COVID-19. He won the 2018 World Food Prize for his work on health and hunger issues. He also was a candidate for the top job at the WHO in 2017 but lost out to Tedros in the final round of voting. Nabarro left the U.N. later that year. In 2003, Nabarro survived a bombing at the U.N. headquarters in Baghdad that killed 22 people, including the High Commissioner for Human Rights at the time, and wounded dozens more. Nabarro, then one of the WHO's senior directors, was in a meeting when 'suddenly there was this extraordinary thud," he told reporters during an emotional news conference days later in Geneva, still carrying his blood-spattered notebook. 'We found some first aid kits, got bandages and turned people onto their sides. We were working like in a cloud, in this fog of moaning and crying,' he recalled. The 4SD Foundation, a social enterprise in Switzerland where Nabarro served as strategic director, said he died Friday in a 'sudden passing.' 'David's generosity and unwavering commitment to improve the lives of others will be sorely missed,' it said. Thuy Maryen, Nabarro's longtime friend and the foundation's former communications director, said he was 75 and died at his home in Ferney-Voltaire, France, a suburb of Geneva. The foundation is focused on mentoring the next generation of leaders in global sustainable development.
Miami Herald
2 days ago
- Miami Herald
David Nabarro, doctor who tried to raise millions to treat cholera in Haiti, dies at 75
The United Nations and world health community are mourning the death of David Nabarro, the British physician and public health champion who led the U.N response to eradicating cholera in Haiti after taking on some of the world's most pressing diseases, including Ebola. A passionate advocate who was once described to the Miami Herald as the U.N.'s go-to guy for responding 'to really tricky' situations, Nabarro died Friday at his home in Ferney-Voltaire, France, a suburb of Geneva, according to the 4SD Foundation, a Switzerland-based social enterprise he founded and where he served as strategic director. He was 75. His passing was described as a 'sudden death.' 'Dr. Nabarro was a tireless advocate for global health -- a leader who brought clarity, compassion and conviction to some of the world's most complex health emergencies, from AIDS and malaria to avian influenza and the COVID-19 pandemic,' Farhan Haq, deputy spokesperson for U.N. Secretary-General António Guterres, said in a statement Tuesday. 'He dedicated his life to the conviction that health is a human right — and worked to help make that right a reality for all people everywhere,' Haq added. Nabarro was known for his organized, results-oriented style and willingness to take personal risks. During the COVID pandemic, he served as one of six special envoys to the World Health Organization dealing with the coronavirus crisis. For his efforts and overall contributions to global health, he was knighted by King Charles III in 2023. Among those contributions was his fight against Ebola. With more than 30 years experience as a public health doctor when he was appointed coordinator of the U.N's efforts, Nabarro ended up raising $3.5 billion to fight Ebola despite the incessant and worrying questions from donors asking him if he knew what he was doing and if he had a strategy. 'There was a question mark always over whether or not we had a strategy that made sense, whether or not we knew what we were up to,'' he told the Herald in a 2016 interview. Soon he faced the same kinds of question as he tried to raise $400 million for the U.N.'s cholera plan in Haiti. Nabarro had been tapped to serve as special adviser to then Secretary-General Ban Ki-moon, who after years of fighting litigation efforts by victims and refusing to acknowledge the U.N.'s role in inadvertently introducing the deadly disease into Haiti, was ready to take it on the problem. Scientific studies and a confidential U.N. report had traced Haiti's outbreak to Nepalese soldiers, part of a U.N. peacekeeping contingent stationed near a river in the rural town of Mirebalais after the devastating Jan. 12, 2010, earthquake. By the time Nabarro was involved cholera had killed at least 9,393 people and sickened more than 790,840 in the Caribbean country. His job was to help the secretary general raise hundreds of millions of dollars over two years to fund a U.N. plan to eliminate cholera with rapid responses, vaccinations and improving long-term access to clean water and sanitation. By the time Nabarro came on the scene in late 2016, Ban had finally admitted the U.N.'s role and offered an apology during a meeting of the U.N. General Assembly. He wanted Nabarro to do for cholera what he had done for Ebola in Africa: galvanize government efforts and raise money. 'I have no illusions about this. It's going to be tough,' Nabarro told the Herald two weeks before visiting Haiti with Ban. 'But I am not scared by it.' Over the next few months, Nabarro made other visits and devoted himself to the cholera problem as well as to the fight against global hunger. To understand the waterborne disease's evolution and response, he reached out to a number of public health experts including Ariel Henry. The physician, who would later serve as Haiti's prime minister, was in the administration of then-President René Préval and was helping with the government's response. At the time Préval was facing immense pressure from the Obama administration to hold presidential and legislative elections in Haiti despite the deaths of more than 300,000 people and 1.5 million homeless in the quake. Fearing that placing blame on the U.N. would lead to the departure of its blue helmet peacekeepers and open the door to more violence and instability, Préval tried to manage the response on his own. But as time went by, pressure built for the U.N. to not only acknowledge its role but to apologize and compensate victims. Instead of checks to victims, Ban called for vaccinating adults and dispatching more rapid response teams within 24 to 48 hours of an infection. He also pledged that the U.N. would improve water and sanitation in places where cholera had spread. In an email exchange in 2017 while vying for the top job at the World Health Organization, Nabarro acknowledged that the effort to raise financing to eradicate cholera in Haiti had not been easy. The amount of money raised was small, but he still held onto hope that the benefits would be enormous. 'I really do hope that I get to the director general of the World Health Organization as I would then be able to give a very high priority to a concerted and sustained effort to reduce the incidence of cholera in the country and to help all Haitians to access drinking water and functioning sanitation,' he told a Herald reporter. Nabarro lost out on the WHO job to Tedros Adhanom Ghebreyesus. In a post on the social media platform X on Saturday, Ghebreyesus remembered Nabarro as 'a great champion of global health and health equity, and a wise, generous mentor to countless individuals.' Through Nabarro's efforts and those of others in Haiti, the country was declared cholera-free in February 2022 by Henry, now the country's prime minister, after three years without a confirmed case. The celebration was short-lived. By the end of the year, repeated gang clashes, which cut off access to water, fuel and hospitals in Port-au-Prince, gave rise to a resurgence of cholera cases. Nabarro is survived by his wife, Flo; his children, Tom, Ollie, Polly, Josie and Lucas, and seven grandchildren.
CBS News
2 days ago
- CBS News
Boston Children's nurse completes virtual Pan-Mass Challenge after missing race for stem cell donation
A Boston Children's Hospital nurse wasn't expecting to be in a hospital bed when she was meant to be riding in the Pan-Mass Challenge, but she was grateful it was for a life-changing reason: stem cell donation. Kristin McIntire is no stranger to long rides. The Boston nurse has completed 10 marathons and several 100-mile bike races. "I love exercise. I love being active," she said, jokingly adding that she commutes to work on her bike. "I don't know if you're familiar with Boston traffic, but it's certainly the most easy way to get around." But for McIntire, riding has always been about more than just fitness. It's personal and it's purposeful. "I've always needed to align that with a higher purpose, that I don't feel like I'm doing it by myself. So whether that's riding with a team, running with a team fundraising for a group, it's been a lot more meaningful for me," McIntire said. For years, McIntire served as a pediatric oncology nurse at Boston Children's Hospital, working on one of the most intense and emotional floors in the building. "There are other outcomes that aren't so great... where the family is leaving without their child," she recalled. "And that's really, really sad." She rides in the Pan-Mass Challenge with Pedal for Pediatrics, a team made up of coworkers that raises money for children and families facing cancer at Dana-Farber and Boston Children's. But last year, just as she was preparing for the big ride, Kristin received a life-changing message: she'd been matched as a stem cell donor. "It was honestly so crazy. I was like, wait, what?" McIntire said. She spent what would've been Pan-Mass Challenge weekend in a hospital bed in Florida, donating stem cells to a stranger with leukemia. "That was a pretty cool reason to stop training, I would say," McIntire said. Though she couldn't be on the course, McIntire found another way to finish the journey. In the weeks after her donation, she completed multiple 50-mile rides virtually. "This team directly provides funding that benefits those patients directly, whether that's ride share services or meal coupons, anything that can help support this family," McIntire said. McIntire has never met the person she helped. She doesn't even know their name. But she knows they're still alive. "I saved a person's life, and I was a little tired after the donation, and that was it," McIntire said. "Whether you're riding, whether you're volunteering, or whether you're out there cheering— all of that matters, and it's very important work," she added. McIntire's stem cell procedure was not a traditional bone marrow surgery. Most donations today are done through a simple outpatient blood draw called peripheral blood stem cell donation. You can learn more or join the registry here.
